This is a working overview of REV-ERB agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-23. Anything still debated is marked as such rather than presented as settled.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Battelli MG, Lorenzoni E (1982). "Purification and properties of a new glutathione-dependent thiol:disulphide oxidoreductase from rat liver". Biochem. J. 207 (1): 133–8. doi:10.1042/bj2070133. PMC 1153833. PMID 6960894.
=== In pediatric peanut allergy === Abrocitinib has the ability to decrease T-cell activation and the allergen-specific basophil in the case of peanut allergy. Subsequently, the in vitro allergic responses of peanut allergy are reduced. Abrocitinib may play the role of an immune modulator in oral immunotherapy of peanut or may be administered alone as monotherapy in cases of allergy to certain food.
=== Prior experiments === From the earliest days of radio technology, signals had been used for navigation using the radio direction finding (RDF) technique. RDF can determine the bearing to a radio transmitter, and several such measurements can be combined to produce a radio fix, allowing the receiver's position to be calculated. Given some basic changes to the broadcast signal, it was possible for the receiver to determine its location using a single station. The UK pioneered one such service in the form of the Orfordness Beacon. Through the early period of radio development it was widely known that certain materials, especially metal, reflected radio signals. This led to the possibility of determining the location of objects by broadcasting a signal and then using RDF to measure the bearing of any reflections. Such a system saw patents issued to Germany's Christian Hülsmeyer in 1904, and widespread experimentation with the basic concept was carried out from then on. These systems revealed only the bearing to the target, not the range, and due to the low power of radio equipment of that era, they were useful only for short-range detection. This led to their use for iceberg and collision warning in fog or bad weather, where all that was required was the rough bearing of nearby objects. The use of radio detection specifically against aircraft was first considered in the early 1930s. Teams in the UK, US, Japan, Germany and others had all considered this concept and put at least some amount of effort into developing it.
Germany is the seventh-largest country in Europe. It borders Denmark to the north; Poland and the Czech Republic to the east; Austria and Switzerland to the south; and France, Luxembourg, Belgium, and the Netherlands to the west. Germany is also bordered by the North Sea (Nordsee) in the northwest and the Baltic Sea (Ostsee) in the northeast. German territory covers 357,022 km2 (137,847 sq mi). Elevation ranges from the mountains of the Alps (with the highest point being the Zugspitze at 2,963 metres or 9,721 feet) in the south to the shores of the North Sea and the Baltic Sea. The forested uplands of central Germany and the lowlands of northern Germany (lowest point: in the municipality Neuendorf-Sachsenbande, Wilstermarsch, at 3.54 metres or 11.6 feet below sea level) are traversed by major rivers such as the Rhine, Danube, and Elbe. Significant natural resources include iron ore, coal, potash, timber, lignite, uranium, copper, natural gas, salt, and nickel.
==== United Kingdom ==== In the United Kingdom, the three medical Royal Colleges (the Royal College of Physicians of London, the Royal College of Physicians of Edinburgh and the Royal College of Physicians and Surgeons of Glasgow) are responsible for setting curricula and training programmes through the Joint Royal Colleges Postgraduate Training Board (JRCPTB), although the process is monitored and accredited by the independent General Medical Council (which also maintains the specialist register). Doctors who have completed medical school spend two years in foundation training completing a basic postgraduate curriculum. After two years of Core Medical Training (CT1/CT2), or three years of Internal Medicine Training (IMT1/IMT2/IMT3) as of 2019, since and attaining the Membership of the Royal College of Physicians, physicians commit to one of the medical specialties:
Sources: en.wikipedia.org
== Education and career == Kessler studied chemistry at the Leipzig University in 1958–1961. He completed his Master (Diplom) in 1963, and his PhD at 1966 with Eugen Müller at the University of Tübingen. In 1969, he underwent habilitation in organic chemistry. He was briefly a university lecturer at Tübingen, then he obtained an organic chemistry lecturer position at the University of Frankfurt am Main. In 1989, he became Professor of organic chemistry and biochemistry at the Technical University of Munich (TUM), where he was in charge of overseeing the installation of one of the four 900 MHz NMR spectrometers in Germany at that time. At TUM, he was Dean of the Faculty of Chemistry, Biology and Earth Sciences from 1994 to 1996. From October 2008, he is a Carl-von-Linde Professor (Emeritus Professor of Excellence) at the TUM Institute for Advanced Study.
Obstructed hernia: is one in which the lumen of the herniated part of the intestine is obstructed. Strangulated hernia: is one in which the blood supply of the hernia contents is cut off, thus leading to ischemia. The lumen of the intestine may be patent or not.
=== Texas research initiative === In 2025, the state of Texas allocated $50 million to fund clinical research on ibogaine, aiming to develop a U.S. Food and Drug Administration-approved treatment for opioid use disorder, co-occurring substance use disorders, and other ibogaine-responsive conditions. The initiative, supported by former Governor Rick Perry, established a consortium of universities, hospitals, and drug developers, with the goal of positioning Texas as a leading center for psychedelic medicine research.
=== Banlieue Triste (2018–2020) === Hangman's Chair's fifth album, Banlieue Triste (lit. 'Sad Suburb'), was released in March 2018 through Music Fear Satan. The album features two guest contributions: one from Marc De Backer of Mucky Pup on "Sidi Bel Abbes", and the other from French synthwave musician Perturbator on "Tired Eyes". Banlieue Triste spawned a music video for "Naive" released in April 2018, starring French actor Nicolas Duvauchelle. Duvauchelle, who was part of the Parisian hardcore scene with his band Cry Havoc and is a longtime friend of Hangman's Chair, stated: "I didn't hesitate for a second. They're such a negative band, and I love it". He played his part as a volunteer. In May, a music video for "Touch the Razor", produced by 12jours (lit. '12days'), was released on Vimeo. On 15 June, they performed at Download Festival France at the Brétigny-sur-Orge Air Base 217.
crest as well as on shirts sold by Wrexham's brick and mortar and virtual fan stores, the partnership ended in 2023 when Wrexham was promoted to the EFL League Two after which US airline United took over the partnership/sponsorship. On 8 January 2026, TikTok announced a new partnership with the FIFA World Cup. In early 2026, the United States and China approved a deal transferring operational control of TikTok's US business to a joint venture led by Oracle and Silver Lake, following a 2024 US law requiring ByteDance to divest the platform over national security concerns. Shou Chew announced in a memo addressed to employees that TikTok will henceforth operate in the United States under a joint investment entity in which the majority ownership will be American. Under the agreement reached, it is guaranteed that Americans will be protected on the social network TikTok through "data protection", "content oversight", and "algorithm security." In April 2026, TikTok partnered with ACRCloud to enhance its SoundOn platform with audio recognition technology aimed at identifying unauthorized or altered uses of copyrighted music. In June 2026, TikTok and Strava launched a joint initiative to support local sports communities across Europe by providing funding and promotional resources to selected creators and community organizations. In July 2026, TikTok announced a multi-year partnership with the NBA and WNBA, expanding access to exclusive content and interactive experiences for basketball fans within the platform.
Sources: en.wikipedia.org
Threonine is one of two proteinogenic amino acids with two stereogenic centers, the other being isoleucine. Threonine can exist in four possible stereoisomers with the following configurations: (2S,3R), (2R,3S), (2S,3S) and (2R,3R). However, the name L-threonine is used for one single stereoisomer, (2S,3R)-2-amino-3-hydroxybutanoic acid. The stereoisomer (2S,3S), which is rarely present in nature, is called L-allothreonine.
==== Sublabial ==== Sublabial administration is achieved by placing the drug between the lip and gum. The frenulum of the tongue may be irritated when in contact with corrosive materials but can be avoided with this route. It is usually used for medications such as nitroglycerin, for example.
=== ZODIAC: Improved molecular formula identification === ZODIAC improves the ranking of the formula candidates provided by SIRIUS. Organisms produce related metabolites derived from multiple but limited biosynthetic pathways. For a full LC-MS/MS run that is derived from a biological sample or any other set of derivatives the relation of the metabolites is reflected in their similarity. Those similarities are in turn reflected in joint fragments and losses between the fragmentation trees and can be leveraged to improve molecular formula identification of the individual molecules. ZODIAC uses the top X molecular formula candidates for each molecule from SIRIUS to build a similarity network, and uses Bayesian statistics to re-rank those candidates. Prior probabilities are derived from fragmentation tree similarity. Finding an optimal solution to the resulting computational problem is NP-hard, therefore Gibbs sampling is used. ZODIAC stands for ZODIAC: Organic compound Determination by Integral Assignment of elemental Compositions.
How a policy institute addresses these largely depends on how they work, their ideology vs. evidence credentials, and the context in which they operate including funding opportunities, the degree and type of competition they have and their staff. This functional method addresses the inherit challenge of defining a think tank. As Simon James said in 1998, "Discussion of think tanks...has a tendency to get bogged down in the vexed question of defining what we mean by 'think tank'—an exercise that often degenerates into futile semantics." It is better (as in the Network Functions Approach) to describe what the organisation should do. Then the shape of the organisation should follow to allow this to happen. The following framework (based on Stephen Yeo's description of think tanks' mode of work) is described in Enrique Mendizabal's blog "onthinktanks": First, policy institutes may work in or base their funding on one or more of:
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.